Patients with end-stage renal disease (ESRD) have a high burden of physical and psychological symptoms. Many remain unrecognized for long periods of time, particularly in older adults. The best strategy to monitor patient-reported outcome measures (PROMs) has not been identified.
Objective:
To assess the feasibility of implementing an iPad-based symptom assessment tool in older adults with ESRD on hemodialysis (HD).
Methods:
We designed an iPad application-delivery system for collecting electronic PROMs (ePROMs). Patient’s ≥60 years of age with ESRD on HD were recruited from a single outpatient dialysis unit. Feasibility was evaluated based on recruitment, retention, and the system usability score (SUS). Assessments were completed at baseline, 3 months, and 6 months after enrollment. ANOVA was used to assess longitudinal symptom variability.
Results:
Twenty-two patients (49% recruitment rate) were enrolled, with an 82% retention at 6 months. Mean age was 69.4 years (SD 6.6), 63.6% were female, and 81.8% were African American. Participants reported minimal difficulty in using the app, with an overall SUS score of 77.6. There were no significant relationships between demographic characteristics (age, race, or education) and SUS. Baseline SF-12 physical score and SF-12 mental score were 40.4 (SD 9.1) and 33.9 (SD 6.7), respectively. No significant changes were seen in longitudinal ePROMs of pain, depression, or anxiety; but was seen in the dialysis symptom index.
Conclusion:
In older patients with ESRD, collection of iPad-based ePROMs is feasible. This process can overcome inefficiencies associated with paper questionnaires and enable systematic monitoring of symptom burden.
MurtaghFCohenLMGermainMJ. Dialysis discontinuation: quo vadis?Adv Chronic Kidney Dis. 2007;14(4):379–401.
2.
OlagunjuATCampbellEAAdeyemiJD. Interplay of anxiety and depression with quality of life in endstage renal disease. Psychosomatics. 2015;56(1):67–77.
3.
WeisbordSDFriedLFArnoldRM, et al.Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16(8):2487–2494.
4.
SainiTMurtaghFEDupontPJMcKinnonPMHatfieldPSaundersY. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliat Med. 2006;20(6):631–636.
5.
Rosenthal AsherDVer HalenNCukorD. Depression and nonadherence predict mortality in hemodialysis treated end-stage renal disease patients. Hemodial Int. 2012;16(3):387–393.
6.
Abbas TavallaiiSEbrahimniaMShamspourNAssariS. Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis. Eur J Intern Med. 2009;20(4):411–414.
7.
DavisonSNJhangriGS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39(3):477–485.
8.
GrincenkovFRFernandesNPereira BdosS, et al.Impact of baseline health-related quality of life scores on survival of incident patients on peritoneal dialysis: a cohort study. Nephron. 2015;129(2):97–103.
9.
AiyegbusiOLKyteDCockwellPAndersonNCalvertM. A patient-centred approach to measuring quality in kidney care: patient-reported outcome measures and patient-reported experience measures. Curr Opin Nephrol Hypertens. 2017;26(6):442–449.
10.
ChanKYChengHWYapDY, et al.Reduction of acute hospital admissions and improvement in outpatient attendance by intensified renal palliative care clinic follow-up: the Hong Kong experience. J Pain Symptom Manage. 2015;49(1):144–149.
11.
WhitfordKShahNDMoriartyJBrandaMThorsteinsdottirB. Impact of a palliative care consult service. Am J Hosp Palliat Care. 2014;31(2):175–182.
12.
IrwinKEGreerJAKhatibJTemelJSPirlWF. Early palliative care and metastatic non-small cell lung cancer: potential mechanisms of prolonged survival. Chron Respir Dis. 2013;10(1):35–47.
13.
RanganathanADoughertyMWaiteDCasarettD. Can palliative home care reduce 30-day readmissions? Results of a propensity score matched cohort study. J Palliat Med. 2013;16(10):1290–1293.
14.
Clinical practice guidelines on shared decision-making in the appropriate initiation of and withdrawal from dialysis. Renal Physicians Association/American Society of Nephrology Working Group. J Am Soc Nephrol. 2000;11(7):1340–1342.
KyteDBishopJBrettellE, et al.Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol. BMJ Open. 2018;8(10):e026080.
17.
SaadMMEl DouaihyYBoumitriC, et al.Predictors of quality of life in patients with end-stage renal disease on hemodialysis. Int J Nephrol Renovasc Dis. 2015;8:119–123.
18.
JakubowskiKPJhambMYabesJ, et al.Technology-assisted cognitive-behavioral therapy intervention for end-stage renal disease. Transl Behav Med. 2019;10(3):657–663.
19.
HernarIGraueMRichardsD, et al.Electronic capturing of patient-reported outcome measures on a touchscreen computer in clinical diabetes practice (the DiaPROM trial): a feasibility study. Pilot Feasibility Stud. 2019;5:29.
20.
CarrascoSSymesL.Patient use of electronic methods to self-report symptoms: an integrative literature review. Oncol Nurs Forum. 2018;45(3):399–416.
21.
AndersonNECalvertMCockwellPDuttonMAiyegbusiOLKyteD. Using patient-reported outcome measures (PROMs) to promote quality of care in the management of patients with established kidney disease requiring treatment with haemodialysis in the UK (PROM-HD): a qualitative study protocol. BMJ Open. 2018;8(10) e021532.
22.
AiyegbusiOLKyteDCockwellP, et al.Patient and clinician perspectives on electronic patient-reported outcome measures in the management of advanced CKD: a qualitative study. Am J Kidney Dis. 2019;74(2):167–178.
23.
Schick-MakaroffKMolzahnA. Brief communication: patient satisfaction with the use of tablet computers: a pilot study in two outpatient home dialysis clinics. Can J Kidney Health Dis. 2014;1:22.
24.
O’ConnellSPalmerRWithersKSahaNPuntoniSCarolan-ReesG. Requirements for the collection of electronic PROMS either “in clinic” or “at home” as part of the PROMs, PREMs and effectiveness programme (PPEP) in Wales: a feasibility study using a generic PROM tool. Pilot Feasibility Stud. 2018;4:90.
25.
LangfordDPFleigLBrownKC, et al.Back to the future—feasibility of recruitment and retention to patient education and telephone follow-up after hip fracture: a pilot randomized controlled trial. Patient Prefer Adherence. 2015;9:1343–1351.
26.
Blatch-JonesAJPekWKirkpatrickEAshton-KeyM. Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study. BMJ Open. 2018;8(9):e022233.
27.
WaltersSJAnjos Henriques-CadbyIBDBortolamiO, et al.Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open. 2017;7(3):e015276.
28.
AbshireMDinglasVDCajitaMIEakinMNNeedhamDMHimmelfarbCD. Participant retention practices in longitudinal clinical research studies with high retention rates. BMC Med Res Methodol. 2017;17(1):30.
29.
BangorAKortumPTMillerJT. An empirical evaluation of the system usability scale. Int J Human Com Interact. 2008;24(6):574–594.
30.
DworkinRHTurkDCRevickiDA, et al.Development and initial validation of an expanded and revised version of the short-form McGill pain questionnaire (SF-MPQ-2). Pain. 2009;144(1-2):35–42.
31.
WatnickSWangPLDemaduraTGanziniL. Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis. 2005;46(5):919–924.
32.
KroenkeKSpitzerRLWilliamsJBLoweB.The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–359.
33.
WeisbordSDFriedLFArnoldRM, et al.Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. J Pain Symptom Manage. 2004;27(3):226–240.
34.
HaysRDKallichJDMapesDLCoonsSJCarterWB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329–338.
35.
PeipertJDBentlerPMKlickoKHaysRD. Psychometric properties of the kidney disease quality of life 36-item short-form survey (KDQOL-36) in the United States. Am J Kidney Dis. 2018;71(4):461–468.
36.
WareJKosinskiMKellerS.SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. Boston Massachusetts: The Health Institute, New England Medical Center; 1998.
37.
RAND Health. Kidney Disease Quality of Life Instrument (KDQOL). RAND; 2017.
38.
VermeulenKThasOVansteelandtS. Increasing the power of the Mann-Whitney test in randomized experiments through flexible covariate adjustment. Stat Med. 2015;34(6):1012–1030.
39.
Hawley-HagueHTacconiCMelloneS, et al.Can smartphone technology be used to support an effective home exercise intervention to prevent falls amongst community dwelling older adults?: the TOGETHER feasibility RCT study protocol. BMJ Open. 2019;9(9):e028100.
40.
CoonsSJEremencoSLundyJJO’DonohoePO’GormanHMaliziaW.Capturing patient-reported outcome (PRO) data electronically: the past, present, and promise of ePRO measurement in clinical trials. Patient. 2015;8(4):301–309.
41.
Soto-ReyIRehrMBrulandP, et al.Electronic collection of multilingual patient-reported outcomes across Europe. Methods Inf Med. 2018;57(S 02):e107–e114.
42.
PittmanZCJohnSGMcIntyreCW. Collection of daily patient reported outcomes is feasible and demonstrates differential patient experience in chronic kidney disease. Hemodial Int. 2017;21(2):265–273.
43.
BreckenridgeKBekkerHLGibbonsE, et al.How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrol Dial Transplant. 2015;30(10):1605–1614.
